ARS Pharmaceuticals annual total assets
2020
2021
2022
2023
2024
2025
ARS Pharmaceuticals Total Assets Growth & History (SPRY)
ARS Pharmaceuticals's total assets was $327.7M for fiscal 2025.
View full ARS Pharmaceuticals company overviewARS Pharmaceuticals annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $327.7M | −$23.5M | −6.69% |
| 2024 | 2024-12-31 | $351.2M | $118.0M | +50.59% |
| 2023 | 2023-12-31 | $233.2M | −$48.2M | −17.14% |
| 2022 | 2022-12-31 | $281.4M | $220.0M | +358.02% |
| 2021 | 2021-12-31 | $61.4M | −$333.4M | −84.44% |
| 2020 | 2020-12-31 | $394.8M | — | — |
ARS Pharmaceuticals quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $249.5M | −$64.0M | −20.41% |
| Q1 2026 | 2026-03-31 | $287.6M | −$39.7M | −12.14% |
| Q4 2025 | 2025-12-31 | $327.7M | −$23.5M | −6.69% |
| Q3 2025 | 2025-09-30 | $372.8M | $155.2M | +71.32% |
| Q2 2025 | 2025-06-30 | $313.5M | $91.5M | +41.23% |
| Q1 2025 | 2025-03-31 | $327.3M | $99.7M | +43.82% |
| Q4 2024 | 2024-12-31 | $351.2M | $118.0M | +50.59% |
| Q3 2024 | 2024-09-30 | $217.6M | −$31.0M | −12.45% |
| Q2 2024 | 2024-06-30 | $222.0M | −$36.8M | −14.22% |
| Q1 2024 | 2024-03-31 | $227.6M | −$43.6M | −16.08% |
| Q4 2023 | 2023-12-31 | $233.2M | −$48.2M | −17.14% |
| Q3 2023 | 2023-09-30 | $248.6M | −$22.5M | −8.30% |
| Q2 2023 | 2023-06-30 | $258.8M | −$35.2M | −11.99% |
| Q1 2023 | 2023-03-31 | $271.2M | −$41.3M | −13.21% |
| Q4 2022 | 2022-12-31 | $281.4M | $220.0M | +358.02% |
| Q3 2022 | 2022-09-30 | $271.1M | −$81.5M | −23.12% |
| Q2 2022 | 2022-06-30 | $294.0M | −$73.0M | −19.89% |
| Q1 2022 | 2022-03-31 | $312.5M | −$69.7M | −18.24% |
| Q4 2021 | 2021-12-31 | $61.4M | −$333.4M | −84.44% |
| Q3 2021 | 2021-09-30 | $352.6M | — | — |
| Q2 2021 | 2021-06-30 | $367.0M | — | — |
| Q1 2021 | 2021-03-31 | $382.2M | — | — |
| Q4 2020 | 2020-12-31 | $394.8M | — | — |
ARS Pharmaceuticals total assets trends
Over the last five fiscal years, ARS Pharmaceuticals's total assets decreased from $394.8M to $327.7M, a change of −$67.2M. The latest reported quarter, Q2 2026, shows $249.5M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ARS Pharmaceuticals source filings ↗